These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25372252)

  • 21. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
    Cook-Bolden FE
    J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product.
    Leyden JJ; Hickman JG; Jarratt MT; Stewart DM; Levy SF
    J Cutan Med Surg; 2001; 5(1):37-42. PubMed ID: 11281433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of fixed-combination acne treatment in adolescents.
    Gold LS
    Cutis; 2013 Mar; 91(3):152-9. PubMed ID: 23617089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
    Dhawan SS
    Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.
    Thiboutot D; Zaenglein A; Weiss J; Webster G; Calvarese B; Chen D
    J Am Acad Dermatol; 2008 Nov; 59(5):792-800. PubMed ID: 18805603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
    Bowman S; Gold M; Nasir A; Vamvakias G
    J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris.
    Ellis CN; Leyden J; Katz HI; Goldfarb MT; Hickman J; Jones TM; Tschen E
    Cutis; 2001 Feb; 67(2 Suppl):13-20. PubMed ID: 11236210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fixed-combination monotherapy with clindamycin 1%- benzoyl peroxide 5% gel: focus on acne patient benefits and clinical use. Introduction.
    Eichenfield L
    Cutis; 2009 Nov; 84(5 Suppl):3-4. PubMed ID: 19999186
    [No Abstract]   [Full Text] [Related]  

  • 29. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
    Tanghetti E; Kircik L; Wilson D; Dhawan S
    J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris.
    Zeichner JA; Wong V; Linkner RV; Haddican M
    J Drugs Dermatol; 2013 Mar; 12(3):277-82. PubMed ID: 23545909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Sheehan-Dare R; Layton A
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):311-9. PubMed ID: 17309451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When do efficacy outcomes in clinical trials correlate with clinical relevance? analysis of clindamycin phosphate 1.2%-benzoyl peroxide 3.75% gel in moderate to severe acne vulgaris.
    Del Rosso JQ
    Cutis; 2016 Jul; 98(1):21-5. PubMed ID: 27529706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; Alió Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.
    Kircik L; Green L; Thiboutot D; Tanghetti E; Wilson D; Dhawan S; Parr L
    J Drugs Dermatol; 2009 Sep; 8(9):812-8. PubMed ID: 19746673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.
    Draelos ZD; Tanghetti EA;
    Cutis; 2002 Feb; 69(2 Suppl):20-9. PubMed ID: 12095065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of topical clindamycin phosphate, benzoyl peroxide, and a combination of the two for the treatment of acne vulgaris.
    Tucker SB; Tausend R; Cochran R; Flannigan SA
    Br J Dermatol; 1984 Apr; 110(4):487-92. PubMed ID: 6231942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
    Eichenfield LF; Alió Sáenz AB
    J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.
    Webster G; Thiboutot DM; Chen DM; Merikle E
    Cutis; 2010 Nov; 86(5):263-7. PubMed ID: 21214129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Chu A; Goulden V; Ambroziak M
    Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
    Tanghetti E; Abramovits W; Solomon B; Loven K; Shalita A
    J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.